INTCO Medical Recognized as an ESG Value Leader at the Jing Chao Awards of 2025

INTCO Medical (300677.SZ) has recently been awarded the Jing Chao Awards of 2025 – ESG Value Listed Company, highlighting its exemplary practices and long-term commitment to environmental stewardship, social responsibility, and corporate governance.
The award, jointly organized by prominent financial media and capital market evaluation institutions, honors listed companies that demonstrate outstanding performance in sustainability, governance excellence, and enduring value creation.

This accolade underscores INTCO Medical’s continued leadership in advancing high-quality development while actively fulfilling its responsibilities to society, further strengthening its reputation among investors and the broader public.

As a leading global manufacturer of medical consumables and devices, INTCO Medical has systematically integrated ESG considerations into its corporate strategy and daily operations. The company has built a robust sustainability framework covering governance, production, and operational management.

By publishing ESG reports on a regular basis, INTCO Medical enhances transparency and accountability. In response to national carbon neutrality objectives, the company has accelerated the adoption of green manufacturing practices and low-carbon technologies, achieving measurable reductions in carbon emissions across product life cycles and steadily increasing the use of clean energy. These initiatives position INTCO Medical at the forefront of low-carbon transformation within the industry.

Social responsibility remains a core pillar of INTCO Medical’s ESG strategy. Guided by the values of “care, goodwill, and authenticity,” the company promotes diversity, equity, and inclusion while continuously upgrading its employee training and development systems. Through comprehensive employee welfare programs and professional growth opportunities, INTCO Medical cultivates a motivated and resilient workforce.
Beyond the workplace, the company actively supports public welfare initiatives, contributing to community health education, charitable causes, and industrial development programs, reflecting a strong sense of corporate citizenship.

In terms of governance, INTCO Medical maintains a sound and modern corporate governance structure, emphasizing compliance, internal controls, and transparent disclosure. These governance practices ensure prudent decision-making and provide a solid foundation for sustainable, long-term growth.
With the increasing sophistication of ESG assessment frameworks in capital markets, INTCO Medical has consistently earned strong evaluations from both domestic and international rating agencies, expanding its global influence in sustainable development.

The Jing Chao Awards of 2025 – ESG Value Listed Company recognition represents both an affirmation of INTCO Medical’s ESG achievements to date and a vote of confidence in its future direction. Looking ahead, the company will continue to deepen ESG integration across all aspects of its business, driving the synergy between sustainability and commercial value, and contributing to the green transformation of the healthcare industry and the sustainable development of society.